确定ARHGAP9作为腹腔大动脉动脉瘤的关键诊断标记物,通过多组学和实验验证
1Department of General Surgery, Qinghai Province People's Hospital, Xining, Qinghai, China.
Human mutation
|September 25, 2025
概括
研究人员确定ARHGAP9是腹腔大动脉动脉瘤 (AAA) 的关键诊断标志物. 这一发现可能会为AAA患者提供更好的早期检测和个性化治疗.
科学领域:
- 血管生物学 血管生物学
- 生物标志物发现发现
- 机器学习在医学中的应用
背景情况:
- 腹腔大动脉瘤 (AAA) 具有严重的危及生命的风险,在早期检测和风险评估方面存在持续的挑战.
- 新型生物标志物对于改善AAA的早期诊断和风险分层至关重要,使个性化医疗干预成为可能.
研究的目的:
- 使用机器学习算法识别AAA的关键诊断标记.
- 探索已识别的基因在AAA病变发生过程中的功能性作用.
- 开发和验证AAA的预测诊断模型.
主要方法:
- 应用各种机器学习算法用于生物标记物识别.
- 基因丰富分析以阐明AAA中的基因功能.
- 使用机器学习构建和验证诊断模型.
- 在体外实验中评估ARHGAP9对血管光滑肌细胞 (VSMCs) 的功能影响.
主要成果:
- 机器学习识别了ARHGAP9作为AAA的中央诊断标记.
- 已识别的关键基因与AAA中的免疫微环境和代谢变化有关.
- 经过验证的诊断模型显示出出色的预测性能.
- 抑制ARHGAP9显著损害了VSMC的扩散.
结论:
- ARHGAP9在AAA病原和血管光滑肌肉细胞功能中发挥着重要作用.
- 开发的诊断模型在预测AAA时表现出很高的准确性.
- ARHGAP9有可能成为腹腔大动脉动脉瘤的新型诊断和治疗标志物.
相关概念视频
Aneurysm II: Clinical Manifestations and Diagnostic Studies
299
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
299
Aneurysm I: Introduction
370
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
370


